Načítá se...
Impact of bivalirudin on mortality and bleeding complications in acute coronary syndrome patients undergoing invasive revascularization: A real world experience
BACKGROUND: In a retrospective analysis of a prospective single center registry we compared the use of bivalirudin, unfractionated heparin (UFH) monotherapy, UFH + abciximab in 1240 consecutive patients with acute coronary syndrome (ACS) undergoing stent implantation. RESULTS: Bivalirudin was associ...
Uloženo v:
Vydáno v: | Wien Klin Wochenschr |
---|---|
Hlavní autoři: | , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Springer Vienna
2016
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161760/ https://ncbi.nlm.nih.gov/pubmed/27624328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00508-016-1078-6 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|